6
Views
0
CrossRef citations to date
0
Altmetric
Research

Patent Evaluation Cardiovascular & Renal: HMG-CoA reductase inhibitors

Pages 77-78 | Published online: 29 Feb 2008

References

  • ROSS R: The pathogenesis of atherosclerosis: a perspec-tive for the 1990's. Nature (1993) 362:801–809.
  • EGASHIRA K et al.: Reduction in serum cholesterol withpravastatin improves endothelium-dependent coro-nary vasomotion in patients with hypercholesterolae-mia. Circulation (1994) 89:2519–2524.
  • KOGA T et al.: Tissue selectivity of pravastatin sodium,lovastatin and simvastatin. The relationship between inhibition of de novo synthesis and active drug concen-trations in the liver, spleen and testis in rat. Eur. J. Biochem. (1992) 209:315–319.
  • LEUNG WH et al.: Beneficial effect of cholesterol-lower-ing therapy on coronary endothelium-dependent re-laxation in hypercholesterolenaic patients. Lancet (1993) 341:1496–1500.
  • LIJUAN M et al: Enhancement of migration activity in cholesterol-poor endothelial cells by pre-treating with HMG-CoA reductase inhibitors. Biochem. Biopbys. Res. Comm. (1994) 203:1355–1361.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.